Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENELOPE-B: Palbociclib in High-Risk Early Breast Cancer
NCT01864746Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Oct 2013
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by GBG Forschungs. Started Oct 2013; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01864746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864746.